Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.

Authors

• Darla K Liles
• Nirmish R Shah
• Brigid Scullin
• Victor R Gordeuk
• Wally R Smith
• Julie Kanter
• Maureen M Achebe
• Ralph Boccia
• Shelley E Crary
• Walter K Kraft
• Natasha Archer
• Vince Cataldo
• Brandon M Hardesty
• Modupe Idowu
• Payal C Desai
• Alan Ikeda
• Geetha Puthenveetil
• Kathryn L Hassell
• Sharada Sarnaik
• Abdullah Kutlar

Publication/Presentation Date

11-1-2021

Volume

195

Issue

4

First Page

150

Last Page

150

ISSN

1365-2141

Published In/Presented At

Liles, D. K., Shah, N. R., Scullin, B., Gordeuk, V. R., Smith, W. R., Kanter, J., Achebe, M. M., Boccia, R., Crary, S. E., Kraft, W. K., Archer, N., Cataldo, V., Hardesty, B. M., Idowu, M., Desai, P. C., Ikeda, A., Puthenveetil, G., Hassell, K. L., Sarnaik, S., & Kutlar, A. (2021). Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study. British journal of haematology, 195(4), e150–e153. https://doi.org/10.1111/bjh.17739

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

34611900

Department(s)

Administration and Leadership

Document Type

Article